15-<wbr/>keto-<wbr/>17-<wbr/>phenyl trinor Prostaglandin F<sub>2?</sub>

15-keto-17-phenyl trinor Prostaglandin F2?

CAT N°: 16817
Price:

From 95.00 80.75

Bimatoprost is an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug.{8838} Oxidation of the C-15 hydroxyl group and amide hydrolysis of Bimatoprost produces 15-keto-17-phenyl trinor PGF2?. 15-keto-17-phenyl trinor PGF2? is a potential metabolite of bimatoprost when administered to animals. 15-keto PG analogs are potential minor impurities in commercial preparations of their corresponding bulk drug compounds. Although much less potent that the parent compound, 15-keto PGs still retain the ability to produce a small but measurable decrease (1 mm Hg) in the intraocular pressure of normal cynomolgus monkeys when administered at a dose of 1 µg/eye.{1107} 15-keto Latanoprost (15-keto-17-phenyl-13,14-dihydro trinor PGF2? isopropyl ester) is a miotic in the normal cat eye, causing an 8 mm reduction in pupillary diameter at 5 µg/eye. Again, this is not as potent as many other F-type PGs; for example, PGF2? will produce this degree of miosis at a dose of less than 1 µg/eye.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 9?,11?-dihydroxy-15-oxo-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-oic acid
  • Correlated keywords
    • oxidation lantoprost bimatoprost eyes ophthalmology ophthalmological intraocular glaucoma esters FP receptors 15-keto-17-phenyl-trinor PGF2.alpha. agonists IOP pressure prostaglandins 15-keto-17-phenyl-trinor PGF2alpha prostaglandins
  • Product Overview:
    Bimatoprost is an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug.{8838} Oxidation of the C-15 hydroxyl group and amide hydrolysis of Bimatoprost produces 15-keto-17-phenyl trinor PGF2?. 15-keto-17-phenyl trinor PGF2? is a potential metabolite of bimatoprost when administered to animals. 15-keto PG analogs are potential minor impurities in commercial preparations of their corresponding bulk drug compounds. Although much less potent that the parent compound, 15-keto PGs still retain the ability to produce a small but measurable decrease (1 mm Hg) in the intraocular pressure of normal cynomolgus monkeys when administered at a dose of 1 µg/eye.{1107} 15-keto Latanoprost (15-keto-17-phenyl-13,14-dihydro trinor PGF2? isopropyl ester) is a miotic in the normal cat eye, causing an 8 mm reduction in pupillary diameter at 5 µg/eye. Again, this is not as potent as many other F-type PGs; for example, PGF2? will produce this degree of miosis at a dose of less than 1 µg/eye.

We also advise you